TANEA MONTGOMERY: Open Payments
NPI 1891199873 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 42 payments from 10 companies in 2025. Trend: 2023 $1,120 · 2024 $1,183 · 2025 $1,490
Food & beverage: $1,204Education: $286
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $302 |
| SOBI, INC | 5 | $239 |
| Lilly USA, LLC | 5 | $210 |
| Syndax Pharmaceuticals, Inc. | 6 | $195 |
| AstraZeneca Pharmaceuticals LP | 5 | $166 |
| Incyte Corporation | 5 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $120 |
| Celgene Corporation | 2 | $55 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $29 |
Products named: CALQUENCE, Cresemba, JAKAFI, Vonjo, SCEMBLIX, JAYPIRCA, Doptelet, REBLOZYL.
Industry payments across TX — which companies pay providers there.
